Dr. Alexandra Lajoie, MD

Dr. Lajoie practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Lajoie's NPI, 1760707830, was assigned on April 1, 2010. Dr. Lajoie graduated from Vagelos College of Physicians and Surgeons in 2010. Dr. Lajoie holds California license A125777.

Dr. Lajoie's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Lajoie's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Lajoie is also affiliated with Providence Saint John's Health Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Lajoie to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lajoie practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lajoie's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Lajoie is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Lajoie's licenses on file in 4 states: California, Wyoming, Washington and Alaska.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Lajoie treats.

CMS data shows 14,085 Medicare services from Dr. Lajoie across 26 procedure codes in 2024, for 765 Medicare patients. Medicare paid $255,809 for them.

CMS counts 765 Medicare patients who saw Dr. Lajoie in 2024. The largest group is 75 to 84, with 351 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lajoie's median patient age at 74, with 57% women.

In 2024, Dr. Lajoie wrote 3,466 Medicare Part D claims for 482 patients. 84% of them were for generic drugs. CMS names the drug for 3,222 of them, across 40 drugs with 11 or more claims each, at $590,024 in total drug cost. In 2023, CMS named 3,265 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Lajoie for performance year 2024, reported as part of a group. Dr. Lajoie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lajoie as offering telehealth.

Dmand AI links 1 paper to Dr. Lajoie in 2008. Dr. Lajoie's most frequent co-authors are Michael F. Chiang, MD and Thomas C. Lee, MD.

CMS Open Payments shows 276 general payments to Dr. Lajoie from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Kiniksa Pharmaceuticals, Ltd. paid the most, $4,698.

Dr. Lajoie graduated from Vagelos College of Physicians and Surgeons in 2010. Dr. Lajoie is a member of ACC.

Dr. Lajoie is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.